“No evident disease activity”: The use of combined assessments in the management of patients with multiple sclerosis

Using combined endpoints to define no evident disease activity (NEDA) is becoming increasingly common when setting targets for treatment outcomes in multiple sclerosis (MS). Historically, NEDA has taken account of the occurrence of relapses, brain magnetic resonance imaging (MRI) lesions and disabil...

Descripción completa

Detalles Bibliográficos
Autores principales: Giovannoni, Gavin, Tomic, Davorka, Bright, Jeremy R, Havrdová, Eva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Topical Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5536258/
https://www.ncbi.nlm.nih.gov/pubmed/28381105
http://dx.doi.org/10.1177/1352458517703193

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5536258/
https://www.ncbi.nlm.nih.gov/pubmed/28381105
http://dx.doi.org/10.1177/1352458517703193

Ejemplares similares